Brown-Forman's Q3 FY25 results showed a 3% decline in net sales to $1.035 billion, a 25% drop in operating income to $280 million, and a 5% decrease in diluted EPS to $0.57. The company attributed the decline to divestitures, lower volumes in certain segments, and foreign exchange effects but maintained confidence in its long-term strategy.
Net sales decreased 3% to $1.035 billion, impacted by divestitures and lower sales in key markets.
Operating income fell 25% to $280 million due to higher costs and restructuring expenses.
Diluted EPS declined 5% to $0.57, primarily due to lower operating income.
The company reaffirmed its full-year guidance for 2-4% organic net sales and operating income growth.
Brown-Forman reaffirmed its full-year outlook, expecting organic net sales and operating income growth in the 2-4% range, despite macroeconomic challenges.